Ces radiol. 2022, 76(2):96-104 | DOI: 10.55095/CesRadiol2022/012
Magnetic resonance imaging findings in neuromyelitis optica spectrum disorders and disease associated with antibodies to myelin oligodendrocyte glycoproteinReview article
- 1 Radiodiagnostická klinika 1. LF UK a VFN, Praha
- 2 Neurologická klinika a Centrum klinických neurověd 1. LF UK a VFN, Praha
Neuromyelitis optica is an autoimmune disease of unknown etiology, characterized by involvement of the optic nerves and spinal cord, the main features of which have been widened to include involvement of the dorsal part of the medulla oblongata (area postrema). The disease primarily involves astrocytes. In MRI, the lesions are mainly in the areas where the water channel - aquaporin 4 is expressed. These are the lesions in the diencephalon, periependymally around the lateral ventricles or ventricle IV. The brain MRI may also show non-specific white matter lesions or pyramidal pathway involvement, which is not associated with increased aquaporin 4 expression. Intramedullary involvement is most often in the form of longitudinal extensive transverse myelitis, when the lesion reaches the height of at least three vertebral bodies. The lesions primarily affect the grey matter, are often extensive and cover more than 50% of the spinal cord area. Optic nerve involvement is typically dorsal, affecting the chiasma and optic tract.
Myelin oligodendrocyte glycoprotein antibody-associated disease is a recently identified autoimmune disease that manifests as CNS demyelination, occurs in both adults and children, and can be both relapsing-remitting and monophasic. MRI features depend on the age of the patient; in children the predominant involvement is as in acute disseminated encephalomyelitis, in adults optic neuritis is the most common sign. Typically, the anterior segment of the optic nerve is affected bilaterally. Another area that may be affected is the spinal cord, where longitudinal extensive transverse myelitis tends to occur; the spinal conus is more commonly affected. In the brain parenchyma, the features tend to be non-specific, with lesions affecting both white and grey matter.
Keywords: magnetic resonance imaging, neuromyelitis optica spectrum disorders, disease associated with antibodies to myelin oligodendrocyte glycoprotein, multiple sclerosis
Grants and funding:
Práce byla podpořena MZ ČR, výzkumným záměrem RVO 64165 a grantem NV 18-04-00168 a ministerstvem školství - Cooperatio (1. LF, Neuroscience).
Accepted: May 1, 2022; Published: June 1, 2022 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Libertinova J. Epidemiologie, klinický obraz a průběh onemocnění u neuromyelitis optica a onemocnění jejího širšího spektra. Cesk Slov Neurol N 2020; 83/116(Suppl 1): 15-19. doi: 10.14735/amcsnn2020S15
Go to original source...
- Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66(10): 1485-1489.
Go to original source...
Go to PubMed...
- Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.
Go to original source...
Go to PubMed...
- Wingerchuk DM, Banwell B, Cabre P, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85: 177-189.
Go to original source...
Go to PubMed...
- Nytrová N. Historie neuromyelitis optica a onemocnění jejího širšího spektra, vývoj diagnostických kritérií Cesk Slov Neurol N 2020; 83/116(Suppl 1): 5-10. doi: 10.14735/amcsnn2020S5
Go to original source...
- Wynford-Thomas R, Jacob A, et al. Neurological update: MOG antibody disease. J Neurol 2019; 266: 1280-1286.
Go to original source...
Go to PubMed...
- Deneve M, Biotti D, Patsoura S, et al. MRI features of demyelinating disease associated with anti-MOG antibodies in adults. J Neuroradio 2019; 46: 312-318.
Go to original source...
Go to PubMed...
- de Mol CL, Wong Y, van Pelt ED, et al. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler 2020; 26(7): 806-814. doi: 10.1177/1352458519845112
Go to original source...
Go to PubMed...
- Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018; 15(1): 134. doi: 10.1186/s12974-018-1144-2
Go to original source...
Go to PubMed...
- Jauris S, Paul F, Franciotta D. Mechanisms of disease:aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008; 4(4): 202-2014.
Go to original source...
Go to PubMed...
- Kim HJ, Paul F, Lana-Peixoto MA, et al. MRI characteristics of neuromyelitis optica spectrum disorder. Neurology 2015; 84(11): 1165-1173.
Go to original source...
Go to PubMed...
- Huh SY, Kim SH, Hyun JW, et al. Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders. Mult Scler 2017; 23(3): 413-419.
Go to original source...
Go to PubMed...
- Solomon JM, Paul F, Chien C, et al. A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course. Ther Adv Neurol Disord 2021; 14: 17562864211014389. doi: 10.1177/17562864211014389
Go to original source...
Go to PubMed...
- Dutra BG, Rocha AJ, Nunes RH, et al. Neuromyelitis Optica Spectrum disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis. RadioGraphics 2018; 38: 169-193.
Go to original source...
Go to PubMed...
- Vaněčková M, Horáková D, Havrdová E, et al. Retrospektivní studie nálezů na magnetické rezonanci míchy a mozku u pacientů s diagnózou neuromyelitis optica. Cesk Slov Neurol 2010; 73(106): 164-168.
- Ramanathan S, Prelog K, Barnes EH, et al. Radiological differention of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler J 2016; 22: 470-482.
Go to original source...
Go to PubMed...
- Vaněčková M. Nálezy na magnetické rezonanci u neuromyelitis optica a onemocnění jejího širšího spektra. Cesk Slov Neurol N 2020; 83/116(Suppl 1): 20-30. doi: 10.14735/amcsnn2020S20
Go to original source...
- Wang KY, Chetta J, Bains P, et al. Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review. Br J Radiol 2018; 91: 20170690.
Go to original source...
Go to PubMed...
- Pekcevik Y, Orman G, Lee IH, et al. What do we known about brain contrast enhancement patterns in neuromyelitis optica? Clin Imaging 2016; 40: 573-580.
Go to original source...
Go to PubMed...
- Ramanathan S, Prelog K, Barnes EH, et al. Radiological differention of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler J 2016; 22: 470-482.
Go to original source...
Go to PubMed...
- Salama S, Khan M, Shanechi A, et al. MRI differences between MOG antibody disease and AQP4 NMOSD. Mult Scler 2020; 26(14): 1854-1865. doi: 10.1177/1352458519893093
Go to original source...
Go to PubMed...
- Jarius S, Ruprecht K, Kleiter I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients.Part1: fequency, syndrome specificity, influence of disease aktivity, long-term course, association with AQP4-IgG and origin. J Neuroinflammation 2016; 13(1): 279.
Go to original source...
Go to PubMed...
- Ambrosius W, Michalak S, Kozubski W, et al. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management. Int J Mol Sci 2020; 22(1): 100. doi: 10.3390/ijms22010100
Go to original source...
Go to PubMed...
- Ikeda A, Watanabe Y, Kaba H, et al. MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature. Brain and Development 2019; 41: 367-372.
Go to original source...
Go to PubMed...
- Jurynczyk M, Messina S, Woodhall MR, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 2017; 140(12): 3128-3138. doi: 10.1093/brain/awx276
Go to original source...
Go to PubMed...
- Polman C, Reingold S, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of Neurology 2011; 69(2): 292-302. doi: 10.1002/ana.22366
Go to original source...
Go to PubMed...
- Cacciaguerra L, Meani A, Mesaros S, et al. Ann Neurol 2019; 85(3): 371-384. doi: 10.1002/ana.25411
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.